R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K367.6 KBREATA PHARMACEUTICALS INCSep 26, 5:25 PM ET·0001193125-23-242619
- SC 13D/A214.5 KBREATA PHARMACEUTICALS INCSep 26, 4:32 PM ET·0001193125-23-242531
- 8-K178.1 KBREATA PHARMACEUTICALS INCSep 21, 4:05 PM ET·0001193125-23-239558
- SC 13D/A324.7 KBREATA PHARMACEUTICALS INCSep 19, 4:31 PM ET·0001193125-23-237676
- SC 13D47.9 KBREATA PHARMACEUTICALS INCAug 7, 5:21 PM ET·0001193125-23-205093
- SC 13D/A136.6 KBREATA PHARMACEUTICALS INCAug 1, 5:17 PM ET·0001140361-23-037417
- SC 13D/A236.2 KBREATA PHARMACEUTICALS INCJul 31, 4:56 PM ET·0001193125-23-199254
- 8-K1.1 MBREATA PHARMACEUTICALS INCJul 31, 7:01 AM ET·0001193125-23-198543
- 8-K171.6 KBREATA PHARMACEUTICALS INCJul 10, 8:08 PM ET·0000950170-23-032425
- SC 13G101.3 KBREATA PHARMACEUTICALS INCJun 26, 4:46 PM ET·0000902664-23-003736
Insiders
10- Anand BhaskarSVP, Chief Accounting Officer
- BIOGEN INC.See footnotes
- Bir Dawn CarterVP, Chief Commercial Officer
- Castellanos ElaineSee Remarks
- CPMG IncDirector, 10% Owner
- Edwards MartinDirector
- Huff James WarrenDirector, See Remarks
- Khan SaminaSVP, Chief Medical Officer
- Loewen AndreaSVP, Global Regulatory Affairs
- McClellan William D. Jr.Director
Tickers
No tickers on record
Addresses
business
5320 LEGACY DRIVE
PLANO, TX, 75024
mailing
5320 LEGACY DRIVE
PLANO, TX, 75024